Draft Documents To Support Submission of an Electronic Common Technical Document; Availability, 66311 [2011-27658]
Download as PDF
Federal Register / Vol. 76, No. 207 / Wednesday, October 26, 2011 / Notices
Center for Biologics Evaluation and
Research (HFM–25), Food and Drug
Administration, 1401 Rockville Pike,
suite 200N, Rockville, MD 20852, 301–
827–0373, mary.padgett@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0724]
Draft Documents To Support
Submission of an Electronic Common
Technical Document; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; request for comments.
The Food and Drug
Administration (FDA) is announcing the
availability of the following draft
versions of documents that support
making regulatory submissions in
electronic format using the electronic
Common Technical Document (eCTD)
specifications entitled ‘‘The eCTD
Backbone Files Specification for Module
1, version 2.0’’ (which includes the U.S.
regional document type definition,
version 3.0) and ‘‘Comprehensive Table
of Contents Headings and Hierarchy,
version 2.0.’’ Supporting technical files
are also being made available on the
Agency Web site. These draft
documents represent FDA’s major
updates to Module 1 of the eCTD, which
contains regional information.
DATES: Submit either electronic or
written comments on the draft
documents by December 27, 2011.
ADDRESSES: Submit written requests for
single copies of the documents to the
Division of Drug Information, Center for
Drug Evaluation and Research (CDER),
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 51, rm.
2201, Silver Spring, MD 20993–0002; or
Office of Communication, Outreach and
Development (HFM–40), Center for
Biologics Evaluation and Research
(CBER), Food and Drug Administration,
1401 Rockville Pike, suite 200N,
Rockville, MD 20852–1448. Send one
self-addressed adhesive label to assist
that office in processing your requests.
See the SUPPLEMENTARY INFORMATION
section for electronic access to the
documents.
Submit electronic comments on the
draft documents to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Virginia Hussong, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, rm. 1161,
Silver Spring, MD 20993,
Esub@fda.hhs.gov; or Mary Padgett,
jlentini on DSK4TPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:53 Oct 25, 2011
Jkt 226001
I. Background
The eCTD is an International
Conference on Harmonisation (ICH)
standard based on specifications
developed by ICH and its member
parties. CDERCBER have been receiving
submissions in the eCTD format since
2003, and the eCTD has been the
standard for electronic submissions to
CDER and CBER since January 1, 2008.
The majority of new electronic
submissions are now received in eCTD
format. Since adoption of the eCTD
standard, it has become necessary to
update the administrative portion of the
eCTD (Module 1) to reflect regulatory
changes, to provide clarification of
business rules for submission
processing and review, to refine the
characterization of promotional
marketing and advertising material, and
to facilitate automated processing of
submissions. In preparation for the
Module 1 update, FDA is making
available for comment the following
draft documents:
• ‘‘The eCTD Backbone Files
Specification for Module 1, version 2.0’’
provides specifications for creating the
eCTD backbone file for Module 1 for
submission to CDER and CBER. It
should be used in conjunction with the
guidance for industry entitled
‘‘Providing Regulatory Submissions in
Electronic Format—Human
Pharmaceutical Applications and
Related Submissions,’’ which will be
revised as part of the implementation of
the updated eCTD backbone files
specification.
• ‘‘The Comprehensive Table of
Contents Headings and Hierarchy,
version 2.0’’ reflects updated headings
that are specified in the draft document
entitled ‘‘The eCTD Backbone Files
Specification for Module 1, version
2.0,’’ as well as mappings to regulations
and legislation.
Supporting technical files are also being
made available on the Agency Web site.
The draft documents include the
following changes:
• Providing for processing of bundled
submissions (e.g., a supplement can be
applied to more than one new drug
application or biologics license
application),
• Providing detailed contact
information so that companies can
specify points of contacts to discuss
technical matters that may arise with a
submission,
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
66311
• Clarifying headings, and
• Using attributes in place of certain
headings to provide flexibility for future
changes without revising the
specification itself.
The draft documents contain complete
lists of the changes to Module 1.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments regarding the draft
documents. It is only necessary to send
one set of comments. It is no longer
necessary to send two copies of mailed
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
III. Electronic Access
Persons with access to the Internet
may obtain the documents at either
https://www.fda.gov/Drugs/Development
ApprovalProcess/FormsSubmission
Requirements/ElectronicSubmissions/
ucm253101.htm, https://www.fda.gov/
BiologicsBloodVaccines/Guidance
ComplianceRegulatoryInformation/
Guidances/default.htm, or https://
www.regulations.gov.
Dated: October 21, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–27658 Filed 10–25–11; 8:45 am]
BILLING CODE 4160–01–P
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Notice of ACHP Quarterly Business
Meeting
Advisory Council on Historic
Preservation.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the Advisory Council on Historic
Preservation (ACHP) will meet
Thursday, November 10, 2011. The
meeting will be held at 8:30 a.m. in
Room M09 in the Old Post Office
Building, 1100 Pennsylvania Ave., NW.,
Washington, DC 20004.
The ACHP was established by the
National Historic Preservation Act of
1966 (16 U.S.C. 470 et seq.) to advise the
President and Congress on national
historic preservation policy and to
comment upon federal, federally
assisted, and federally licensed
undertakings having an effect upon
properties listed in or eligible for
SUMMARY:
E:\FR\FM\26OCN1.SGM
26OCN1
Agencies
[Federal Register Volume 76, Number 207 (Wednesday, October 26, 2011)]
[Notices]
[Page 66311]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27658]
[[Page 66311]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0724]
Draft Documents To Support Submission of an Electronic Common
Technical Document; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of the following draft versions of documents that support
making regulatory submissions in electronic format using the electronic
Common Technical Document (eCTD) specifications entitled ``The eCTD
Backbone Files Specification for Module 1, version 2.0'' (which
includes the U.S. regional document type definition, version 3.0) and
``Comprehensive Table of Contents Headings and Hierarchy, version
2.0.'' Supporting technical files are also being made available on the
Agency Web site. These draft documents represent FDA's major updates to
Module 1 of the eCTD, which contains regional information.
DATES: Submit either electronic or written comments on the draft
documents by December 27, 2011.
ADDRESSES: Submit written requests for single copies of the documents
to the Division of Drug Information, Center for Drug Evaluation and
Research (CDER), Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 51, rm. 2201, Silver Spring, MD 20993-0002; or Office of
Communication, Outreach and Development (HFM-40), Center for Biologics
Evaluation and Research (CBER), Food and Drug Administration, 1401
Rockville Pike, suite 200N, Rockville, MD 20852-1448. Send one self-
addressed adhesive label to assist that office in processing your
requests. See the SUPPLEMENTARY INFORMATION section for electronic
access to the documents.
Submit electronic comments on the draft documents to https://www.regulations.gov. Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Virginia Hussong, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, rm. 1161, Silver Spring, MD 20993,
Esub@fda.hhs.gov; or Mary Padgett, Center for Biologics Evaluation and
Research (HFM-25), Food and Drug Administration, 1401 Rockville Pike,
suite 200N, Rockville, MD 20852, 301-827-0373,
mary.padgett@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The eCTD is an International Conference on Harmonisation (ICH)
standard based on specifications developed by ICH and its member
parties. CDERCBER have been receiving submissions in the eCTD format
since 2003, and the eCTD has been the standard for electronic
submissions to CDER and CBER since January 1, 2008. The majority of new
electronic submissions are now received in eCTD format. Since adoption
of the eCTD standard, it has become necessary to update the
administrative portion of the eCTD (Module 1) to reflect regulatory
changes, to provide clarification of business rules for submission
processing and review, to refine the characterization of promotional
marketing and advertising material, and to facilitate automated
processing of submissions. In preparation for the Module 1 update, FDA
is making available for comment the following draft documents:
``The eCTD Backbone Files Specification for Module 1,
version 2.0'' provides specifications for creating the eCTD backbone
file for Module 1 for submission to CDER and CBER. It should be used in
conjunction with the guidance for industry entitled ``Providing
Regulatory Submissions in Electronic Format--Human Pharmaceutical
Applications and Related Submissions,'' which will be revised as part
of the implementation of the updated eCTD backbone files specification.
``The Comprehensive Table of Contents Headings and
Hierarchy, version 2.0'' reflects updated headings that are specified
in the draft document entitled ``The eCTD Backbone Files Specification
for Module 1, version 2.0,'' as well as mappings to regulations and
legislation.
Supporting technical files are also being made available on the Agency
Web site.
The draft documents include the following changes:
Providing for processing of bundled submissions (e.g., a
supplement can be applied to more than one new drug application or
biologics license application),
Providing detailed contact information so that companies
can specify points of contacts to discuss technical matters that may
arise with a submission,
Clarifying headings, and
Using attributes in place of certain headings to provide
flexibility for future changes without revising the specification
itself.
The draft documents contain complete lists of the changes to Module 1.
II. Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) either electronic or written comments regarding the
draft documents. It is only necessary to send one set of comments. It
is no longer necessary to send two copies of mailed comments. Identify
comments with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.
III. Electronic Access
Persons with access to the Internet may obtain the documents at
either https://www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/ucm253101.htm, https://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm, or
https://www.regulations.gov.
Dated: October 21, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-27658 Filed 10-25-11; 8:45 am]
BILLING CODE 4160-01-P